Research Using Biosamples and Subjects from Type 1 Diabetes Clinical Studies –Complications (DP3)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) invites applications for studies on the complications of type 1 diabetes using subjects and/or samples from clinical studies on type 1 diabetes.


  • Letter of Intent Due Date: Feb. 3, 2016
  • Application Due Date(s): Mar. 3, 2016, by 5:00 PM local time of applicant organization.

RFA-DK-15-019 Expiration Date March 4, 2016

Agency Website



Amount Description

The maximum direct costs are $1 million for the entire project period. Facilities and Administrative (F&A) costs to be determined at the time of award.  F&A costs requested by consortium participants are not included in the direct cost limitation.

The scope of the proposed project should determine the project period. The maximum project period is 3 years.  

Funding Type





Medical - Basic Science
Medical - Clinical Science

External Deadline

March 3, 2016